Inventor
MANNING DAVID D
US17 patents
⚠️ This page may combine multiple inventors who share the name “MANNING DAVID D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALBANY MOLECULAR RES INC
8 patentsUS7553846B2Jun 30, 2009
2-alkylbenzoxazole carboxamides as 5-HT3 modulators
ALBANY MOLECULAR RES INC10 citations83
US7956050B2Jun 7, 2011
Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
ALBANY MOLECULAR RES INC13 citations81
US7863271B2Jan 4, 2011
2-aminobenzoxazole carboxamides as 5HT3 modulators
ALBANY MOLECULAR RES INC6 citations61
US9045501B2Jun 2, 2015
5-HT3 receptor modulators, methods of making, and use thereof
ALBANY MOLECULAR RES INC0 citations51
US9403776B2Aug 2, 2016
Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
ALBANY MOLECULAR RES INC0 citations49
US7799756B2Sep 21, 2010
Processes for stereoselective synthesis of trans ISATX247
ALBANY MOLECULAR RES INC0 citations48
US8710047B2Apr 29, 2014
5-HT3 receptor modulators, methods of making, and use thereof
ALBANY MOLECULAR RES INC0 citations45
US9352049B2May 31, 2016
Ligand-therapeutic agent conjugates, silicon-based linkers, and methods for making and using them
ALBANY MOLECULAR RES INC0 citations41
MANNING DAVID D
3 patentsUS8278301B2Oct 2, 2012
2-alkylbenzoxazole carboxamides as 5HT3 modulators
MANNING DAVID D0 citations48
US8501729B2Aug 6, 2013
5-HT3 receptor modulators, methods of making, and use thereof
MANNING DAVID D0 citations44
US8124600B2Feb 28, 2012
5-HT3 receptor modulators, methods of making, and use thereof
MANNING DAVID D0 citations44